Cuba resumes cytostatic drug production at AICA plant

The AICA Laboratories plant has restarted operations to manufacture cancer drugs. The move aims to supply the national oncology care program despite economic constraints.

The reactivation of the AICA Laboratories cytostatic drug plant followed an investment process to expand capacity. The restart is proceeding in a phased and controlled manner to ensure medication quality. Mayda Mauri Pérez, president of BioCubaFarma, and Minister of Public Health José Angel Portal Miranda visited the facility. They highlighted the collaboration between the biopharmaceutical industry and the health system. The plant will supply 16 cytostatic drugs to the National Program for the Care of Cancer Patients. Production will prioritize medications of greatest clinical criticality according to schedules agreed with the Ministry of Public Health. Portal Miranda noted that the reopening will help ensure availability of oncology treatments despite current economic restrictions.

관련 기사

Cuban workers repair power infrastructure in Nuevitas after nationwide blackout, with dark Havana skyline and microgrids in background.
AI에 의해 생성된 이미지

Cuba launches recovery after second nationwide blackout in a week

AI에 의해 보고됨 AI에 의해 생성된 이미지

Cuba has begun restoring power following a nationwide grid collapse on Saturday evening—the second total blackout in less than a week and third major outage this month—affecting around 10 million people after a major power plant in Nuevitas failed. Officials established microgrids for essential services amid chronic fuel shortages and grid unreliability.

Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.

AI에 의해 보고됨

Following Comptroller General approval and publication in the Official Gazette, the nationwide oncology sanitary alert—declared by President José Antonio Kast in late March amid delays affecting thousands on cancer waiting lists—has taken effect. It grants the Ministry of Health extraordinary powers to expedite diagnostics and treatments for 33,000 patients until September 30, 2026, with potential extension.

Cabinet Chief Manuel Adorni accompanied National Security Minister Alejandra Monteoliva in a drug destruction operation at Grupo S.A. plant in El Talar. Over 800 kg of cocaine, marijuana, and synthetic drugs were incinerated, along with more than 1,800 kg of chemical precursors. The destroyed material is estimated to be worth over 4 billion pesos on the illegal market.

AI에 의해 보고됨

President José Antonio Kast signed a decree declaring a health alert due to the oncology waiting list emergency, affecting over 27,000 patients. The measure grants extraordinary powers to health authorities to speed up purchases and public-private collaborations. It aims to reduce delays averaging 76.8 to 332 days.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부